These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 23439216

  • 1. Participation of the nociceptin/orphanin FQ receptor in ethanol-mediated locomotor activation and ethanol intake in preweanling rats.
    Miranda-Morales RS, Nizhnikov ME, Waters DH, Spear NE.
    Behav Brain Res; 2013 May 15; 245():137-44. PubMed ID: 23439216
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological characterization of the nociceptin/orphanin FQ receptor on ethanol-mediated motivational effects in infant and adolescent rats.
    Miranda-Morales RS, Pautassi RM.
    Behav Brain Res; 2016 Feb 01; 298(Pt A):88-96. PubMed ID: 25907741
    [Abstract] [Full Text] [Related]

  • 3. Buprenorphine reduces alcohol drinking through activation of the nociceptin/orphanin FQ-NOP receptor system.
    Ciccocioppo R, Economidou D, Rimondini R, Sommer W, Massi M, Heilig M.
    Biol Psychiatry; 2007 Jan 01; 61(1):4-12. PubMed ID: 16533497
    [Abstract] [Full Text] [Related]

  • 4. NOP Receptor Antagonists Decrease Alcohol Drinking in the Dark in C57BL/6J Mice.
    Brunori G, Weger M, Schoch J, Targowska-Duda K, Barnes M, Borruto AM, Rorick-Kehn LM, Zaveri NT, Pintar JE, Ciccocioppo R, Toll L, Cippitelli A.
    Alcohol Clin Exp Res; 2019 Oct 01; 43(10):2167-2178. PubMed ID: 31386211
    [Abstract] [Full Text] [Related]

  • 5. Modification of anxiety-like behaviors by nociceptin/orphanin FQ (N/OFQ) and time-dependent changes in N/OFQ-NOP gene expression following ethanol withdrawal.
    Aujla H, Cannarsa R, Romualdi P, Ciccocioppo R, Martin-Fardon R, Weiss F.
    Addict Biol; 2013 May 01; 18(3):467-79. PubMed ID: 22804785
    [Abstract] [Full Text] [Related]

  • 6. Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor agonists.
    Khroyan TV, Polgar WE, Jiang F, Zaveri NT, Toll L.
    J Pharmacol Exp Ther; 2009 Dec 01; 331(3):946-53. PubMed ID: 19713488
    [Abstract] [Full Text] [Related]

  • 7. Nociceptin/orphanin FQ decreases glutamate transmission and blocks ethanol-induced effects in the central amygdala of naive and ethanol-dependent rats.
    Kallupi M, Varodayan FP, Oleata CS, Correia D, Luu G, Roberto M.
    Neuropsychopharmacology; 2014 Apr 01; 39(5):1081-92. PubMed ID: 24169802
    [Abstract] [Full Text] [Related]

  • 8. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM, Statnick MA, Rorick-Kehn LM, Pintar JE, Ansonoff M, Chen Y, Tucker RC, Ciccocioppo R.
    Pharmacol Ther; 2014 Mar 01; 141(3):283-99. PubMed ID: 24189487
    [Abstract] [Full Text] [Related]

  • 9. Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior.
    Marti M, Mela F, Veronesi C, Guerrini R, Salvadori S, Federici M, Mercuri NB, Rizzi A, Franchi G, Beani L, Bianchi C, Morari M.
    J Neurosci; 2004 Jul 28; 24(30):6659-66. PubMed ID: 15282268
    [Abstract] [Full Text] [Related]

  • 10. The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats.
    Leggett JD, Harbuz MS, Jessop DS, Fulford AJ.
    Neuroscience; 2006 Sep 15; 141(4):2051-7. PubMed ID: 16784820
    [Abstract] [Full Text] [Related]

  • 11. Dysregulation of nociceptin/orphanin FQ activity in the amygdala is linked to excessive alcohol drinking in the rat.
    Economidou D, Hansson AC, Weiss F, Terasmaa A, Sommer WH, Cippitelli A, Fedeli A, Martin-Fardon R, Massi M, Ciccocioppo R, Heilig M.
    Biol Psychiatry; 2008 Aug 01; 64(3):211-8. PubMed ID: 18367152
    [Abstract] [Full Text] [Related]

  • 12. Differential role of mu, delta and kappa opioid receptors in ethanol-mediated locomotor activation and ethanol intake in preweanling rats.
    Arias C, Molina JC, Spear NE.
    Physiol Behav; 2010 Mar 03; 99(3):348-54. PubMed ID: 19954749
    [Abstract] [Full Text] [Related]

  • 13. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.
    Calo G, Rizzi A, Rizzi D, Bigoni R, Guerrini R, Marzola G, Marti M, McDonald J, Morari M, Lambert DG, Salvadori S, Regoli D.
    Br J Pharmacol; 2002 May 03; 136(2):303-11. PubMed ID: 12010780
    [Abstract] [Full Text] [Related]

  • 14. Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs.
    Gavioli EC, Calo' G.
    Pharmacol Ther; 2013 Oct 03; 140(1):10-25. PubMed ID: 23711793
    [Abstract] [Full Text] [Related]

  • 15. Cloning and characterization of the rhesus monkey nociceptin/orphanin FQ receptor.
    Koga K, Ichikawa D, Nambu H, Azuma-Kanoh T, Sakai N, Takaki-Kawagoe H, Ozaki S, Ohta H.
    Genes Genet Syst; 2009 Oct 03; 84(5):319-25. PubMed ID: 20154418
    [Abstract] [Full Text] [Related]

  • 16. Mu-opioid peptide (MOP) and nociceptin/orphanin FQ peptide (NOP) receptor activation both contribute to the discriminative stimulus properties of cebranopadol in the rat.
    Tzschentke TM, Rutten K.
    Neuropharmacology; 2018 Feb 03; 129():100-108. PubMed ID: 29155273
    [Abstract] [Full Text] [Related]

  • 17. Synergistic interaction between the agonism of cebranopadol at nociceptin/orphanin FQ and classical opioid receptors in the rat spinal nerve ligation model.
    Christoph T, Raffa R, De Vry J, Schröder W.
    Pharmacol Res Perspect; 2018 Dec 03; 6(6):e00444. PubMed ID: 30519474
    [Abstract] [Full Text] [Related]

  • 18. Fear expression is reduced after acute and repeated nociceptin/orphanin FQ (NOP) receptor antagonism in rats: therapeutic implications for traumatic stress exposure.
    Taylor RM, Jeong IH, May MD, Bergman EM, Capaldi VF, Moore NLT, Matson LM, Lowery-Gionta EG.
    Psychopharmacology (Berl); 2020 Oct 03; 237(10):2943-2958. PubMed ID: 32588078
    [Abstract] [Full Text] [Related]

  • 19. Stimulation of δ opioid receptor and blockade of nociceptin/orphanin FQ receptor synergistically attenuate parkinsonism.
    Mabrouk OS, Viaro R, Volta M, Ledonne A, Mercuri N, Morari M.
    J Neurosci; 2014 Sep 24; 34(39):12953-62. PubMed ID: 25253844
    [Abstract] [Full Text] [Related]

  • 20. Swim stress enhances nociceptin/orphanin FQ-induced inhibition of rat dorsal raphe nucleus activity in vivo and in vitro: role of corticotropin releasing factor.
    Nazzaro C, Barbieri M, Varani K, Beani L, Valentino RJ, Siniscalchi A.
    Neuropharmacology; 2010 Feb 24; 58(2):457-64. PubMed ID: 19747494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.